NCT02261571 Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer Status UNKNOWN Phase NA
NCT02261415 The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02261051 Symptom Management, Quality of Life and Satisfaction With Care for Advanced Stage Cancers - Control Arm Status WITHDRAWN Phase N/A
NCT02255318 Primary Prevention of Infections Related to Chambers Implantable Catheter by a Taurolodine Lock in Patients With Cancer Receiving Parenteral Nutrition Status UNKNOWN Phase NA
NCT02253251 Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment Status RECRUITING Phase N/A
NCT02250872 Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury Status UNKNOWN Phase PHASE2/PHASE3
NCT02240212 Study of Afuresertib Combined With Paclitaxel in Gastric Cancer Status COMPLETED Phase PHASE1
NCT02239952 HGG-TCP (High Grade Glioma - Tumor Concentrations of Protein Kinase Inhibitors) Status UNKNOWN Phase NA
NCT02239575 Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples Status WITHDRAWN Phase N/A
NCT02235740 A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2) Status TERMINATED Phase PHASE1
NCT02232074 Socio-legal Services for Underserved Populations Through Patient Navigation to Optimize Resources During Treatment Status COMPLETED Phase NA
NCT02224599 Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies Status TERMINATED Phase PHASE1/PHASE2
NCT02223312 Therapy for Progressive and/or Refractory Hematologic Malignancies Status WITHDRAWN Phase PHASE1/PHASE2
NCT02222844 Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers Status RECRUITING Phase NA